Day One Biopharmaceuticals Inc.
DAWN | NASDAQ
$21.53
$0 (0.00%)
At close: Apr 24, 2026, 9:30 AM ET
Institutional Ownership
Net OutflowTotal Institutions
198
Total Ownership
78.74%
Capital Flow
-$156.37M
Shares Change
-3.91M
Ownership Distribution
Institutions (78.74%)
Others (21.26%)
Institutional Sentiment
Overall: bullishEquity Sentiment & Activity
bullishNew Positions
46
Increased Positions
116
Reduced Positions
46
Closed Positions
32
New (46)
Increased (116)
Reduced (46)
Closed (32)
Options Sentiment & Activity
bullishPut/Call Ratio
0.878
Call Flow
645,300
Put Flow
566,700
Calls (53%)
Puts (47%)
Super Investors
| Super Investor / Fund | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Soros Fund Management LLC | 1.49% 0.00% | 0.43% | 1.54M | 33.14M | |
| Point72 Asset Management LP | 0.03% -79.55% | < 0.01% | 31.94K | 687.63K |
Top Shareholders
| Institution | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Blackrock, Inc. | 8.55% -2.12% | < 0.01% +25.31% | 8.84M -1.82% | 82.37M +29.79% | |
| Atlas Venture Life Science Advisors, LLC | 6.20% -0.58% | 6.91% +14.69% | 6.41M -0.28% | 59.77M +31.83% | |
| Vanguard Group Inc | 6.08% +1.33% | < 0.01% +30.13% | 6.28M +1.63% | 58.55M +34.36% |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove DAWN